Patent · US Active

Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor

US10548883B2 · kind B2 · utility

1Cited by

0References

19Claims

0Family size

Assignees

GenFleet Therapeutics (Shanghai) Inc. · CN
Medshine Discovery Inc. · CN

Inventors

Fei Sun · Shanghai, CN
Lifang Wu · Shanghai, CN
Charles Z. Ding · San Mateo, US
Guoping HU · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN
Jianyu LU · Shanghai, CN

Key dates

Filing date	Jun 8, 2017
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Jun 8, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A benzotriazole-derived α and β-unsaturated amide compound used as TGF-βR1 inhibitor or a pharmaceutically acceptable salt thereof, the structure of the compound being as shown in formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.